✦ LIBER ✦

Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats

✍ Scribed by Koch, D. A.; Silva, R. B. M.; de Souza, A. H.; Leite, C. E.; Nicoletti, N. F.; Campos, M. M.; Laufer, S.; Morrone, F. B.

Book ID: 126745584
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 490 KB
Volume: 53
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/ket369

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

✍ Stanley B. Cohen; Tien-Tsai Cheng; Vishala Chindalore; Nemanja Damjanov; Ruben B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Analgesic efficacy and safety of the nov

Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study

✍ Ostenfeld, T.; Krishen, A.; Lai, R.Y.; Bullman, J.; Baines, A.J.; Green, J.; Ana 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 485 KB